COVID-19 Testing – Evidence and Best Practices Product: — Evidence Synthesis Network Serological Testing Signs & Symptoms Testing & Tracing esnetwork.ca Last Updated: June 25, 2020
Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: June 23, 2020 Also available in Français
Influenza Vaccination and Risk of Subsequent Non-Influenza Respiratory Viruses: Safety Product: — Canadian Agency for Drugs and Technologies in Health Vaccine Vaccines & Immunity covid.cadth.ca Last Updated: June 8, 2020 Also available in Français
Health Technology Update, Issue 27 Product: — Canadian Agency for Drugs and Technologies in Health Future Planning New Technology covid.cadth.ca Last Updated: June 5, 2020 Also available in Français
Incremental Benefit of Using a History of Sudden Loss of Taste (Ageusia) And/Or Smell (Anosmia) in Symptom Screening for COVID-19 Product: — Evidence Synthesis Network Less Common Signs & Symptoms Signs & Symptoms Testing & Tracing Tracing esnetwork.ca Last Updated: May 28, 2020
Methoxyflurane for Acute Pain: Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: May 25, 2020 Also available in Français